Izotropic Management
Management criteria checks 2/4
Izotropic's CEO is Bob Thast, appointed in May 2016, has a tenure of 8.67 years. directly owns 6.9% of the company’s shares, worth €463.86K. The average tenure of the management team and the board of directors is 3.3 years and 5 years respectively.
Key information
Bob Thast
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 8.7yrs |
CEO ownership | 6.9% |
Management average tenure | 3.3yrs |
Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Oct 31 2024 | n/a | n/a | -CA$2m |
Jul 31 2024 | n/a | n/a | -CA$2m |
Apr 30 2024 | n/a | n/a | -CA$2m |
Jan 31 2024 | n/a | n/a | -CA$3m |
Oct 31 2023 | n/a | n/a | -CA$5m |
Jul 31 2023 | n/a | n/a | -CA$5m |
Apr 30 2023 | CA$221k | n/a | -CA$6m |
Jan 31 2023 | n/a | n/a | -CA$6m |
Oct 31 2022 | n/a | n/a | -CA$5m |
Jul 31 2022 | n/a | n/a | -CA$6m |
Apr 30 2022 | CA$175k | n/a | -CA$7m |
Jan 31 2022 | n/a | n/a | -CA$7m |
Oct 31 2021 | n/a | n/a | -CA$8m |
Jul 31 2021 | n/a | n/a | -CA$6m |
Apr 30 2021 | CA$135k | CA$135k | -CA$5m |
Jan 31 2021 | n/a | n/a | -CA$4m |
Oct 31 2020 | n/a | n/a | -CA$2m |
Jul 31 2020 | n/a | n/a | -CA$1m |
Apr 30 2020 | CA$78k | CA$78k | -CA$1m |
Compensation vs Market: Insufficient data to establish whether Bob's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Bob's compensation has increased whilst the company is unprofitable.
CEO
Bob Thast (70 yo)
8.7yrs
Tenure
Mr. Robert Louis Thast, also known as Bob, is Founder of Izotropic Corporation and serves as its interim Chief Executive Officer at since June 1, 2023 and has been its Chairman. He serves as the Chief Exec...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 8.7yrs | no data | 6.9% € 463.9k | |
CFO & Director | 2yrs | no data | 0.18% € 11.8k | |
Executive VP of Product Engineering & COO | 2yrs | no data | no data | |
Legal Advisor & Independent Director | 3.3yrs | no data | 0.76% € 50.8k | |
Operations Manager & Corporate Secretary | 4.4yrs | no data | no data |
3.3yrs
Average Tenure
Experienced Management: 1R3's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 8.7yrs | no data | 6.9% € 463.9k | |
CFO & Director | 5.2yrs | no data | 0.18% € 11.8k | |
Legal Advisor & Independent Director | 7.7yrs | no data | 0.76% € 50.8k | |
Medical Device Business Consultant & Member of Advisory Board | no data | no data | no data | |
Senior Advisor & Member of Advisory Board | no data | no data | no data | |
Senior Development & Technology Advisor and Member of Advisory Board | no data | no data | no data | |
Independent Director | 7.7yrs | no data | 1.76% € 118.4k | |
Member of Advisory Board | no data | no data | no data | |
Member of the Advisory Board | 4.8yrs | no data | no data | |
Member of Advisory Board | 4.7yrs | no data | no data | |
Member of Advisory Board | 4.5yrs | no data | no data | |
Member of Scientific Advisory Board | 4yrs | no data | no data |
5.0yrs
Average Tenure
70yo
Average Age
Experienced Board: 1R3's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/12 18:31 |
End of Day Share Price | 2025/01/10 00:00 |
Earnings | 2024/10/31 |
Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Izotropic Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|